The mechanisms of brain ischemic insult and potential protective interventions
暂无分享,去创建一个
[1] M. Welsh,et al. Neuroprotection in Ischemia Blocking Calcium-Permeable Acid-Sensing Ion Channels , 2004, Cell.
[2] Z. Xiong,et al. Differential Roles of NMDA Receptor Subtypes in Ischemic Neuronal Cell Death and Ischemic Tolerance , 2008, Stroke.
[3] M. Ginsberg. The new language of cerebral ischemia. , 1997, AJNR. American journal of neuroradiology.
[4] Y. Namiki,et al. Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury. , 2006, CNS drug reviews.
[5] A. Sun,et al. Novel targets for therapeutic intervention against ischemic brain injury. , 1999, Clinical neuropharmacology.
[6] S. Sharma,et al. Neuroprotective effect of MnTMPyP, a superoxide dismutase/catalase mimetic in global cerebral ischemia is mediated through reduction of oxidative stress and DNA fragmentation. , 2007, European journal of pharmacology.
[7] E. Hall,et al. Dose-response analysis of the effect of 21-aminosteroid tirilazad mesylate (U-74006F) upon neurological outcome and ischemic brain damage in permanent focal cerebral ischemia , 1994, Brain Research.
[8] M. Maze,et al. Xenon and Sevoflurane Protect against Brain Injury in a Neonatal Asphyxia Model , 2008, Anesthesiology.
[9] B. Siesjö,et al. Calcium in ischemic cell death. , 1998, Stroke.
[10] K. Hossmann. Pathophysiology and Therapy of Experimental Stroke , 2006, Cellular and Molecular Neurobiology.
[11] M. Rice,et al. Brain edema induced by in vitro ischemia: causal factors and neuroprotection , 2003, Journal of neurochemistry.
[12] Stevan R. Hubbard,et al. IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA , 2002, Nature.
[13] D. Ron,et al. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase , 1999, Nature.
[14] C. Borner,et al. Apoptotic crosstalk between the endoplasmic reticulum and mitochondria controlled by Bcl-2 , 2000, Oncogene.
[15] Feng Li,et al. The mechanisms of brain ischemic insult and potential protective interventions , 2009, Neuroscience bulletin.
[16] F. Shibasaki,et al. A novel neuroprotective compound FR901459 with dual inhibition of calcineurin and cyclophilins. , 2006, Acta neurochirurgica. Supplement.
[17] Toru Iwama,et al. The Experimental and Clinical Pharmacology of Propofol, an Anesthetic Agent with Neuroprotective Properties , 2008, CNS neuroscience & therapeutics.
[18] Yiwen Ruan,et al. Dopamine D1-Like Receptors Depress Excitatory Synaptic Transmissions in Striatal Neurons After Transient Forebrain Ischemia , 2008, Stroke.
[19] Junying Yuan,et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β , 2000, Nature.
[20] K. Maiese,et al. Protein kinases modulate the sensitivity of hippocampal neurons to nitric oxide toxicity and anoxia , 1993, Journal of neuroscience research.
[21] M. Moskowitz,et al. Focal Ischemic Preconditioning Induces Rapid Tolerance to Middle Cerebral Artery Occlusion in Mice , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[22] W. Paschen,et al. Endoplasmic reticulum stress response and neurodegeneration. , 2005, Cell calcium.
[23] V. Carraro,et al. Induction of CHOP Expression by Amino Acid Limitation Requires Both ATF4 Expression and ATF2 Phosphorylation* , 2004, Journal of Biological Chemistry.
[24] A Schurr,et al. Neuroprotection against ischemic/hypoxic brain damage: blockers of ionotropic glutamate receptor and voltage sensitive calcium channels. , 2004, Current drug targets.
[25] S. Oyadomari,et al. Roles of CHOP/GADD153 in endoplasmic reticulum stress , 2004, Cell Death and Differentiation.
[26] M. Moseley,et al. Time-course and treatment response with SNX-111, an N-type calcium channel blocker, in a rodent model of focal cerebral ischemia using diffusion-weighted MRI , 1996, Brain Research.
[27] M. Zawadzka,et al. Molecular mechanisms of neuroprotective action of immunosuppressants ‐ facts and hypotheses , 2004, Journal of cellular and molecular medicine.
[28] DanieleBano,et al. Ca2+ Signals and Neuronal Death in Brain Ischemia , 2007 .
[29] M. O'Neill,et al. Dopamine D2 receptor agonists protect against ischaemia-induced hippocampal neurodegeneration in global cerebral ischaemia. , 1998, European journal of pharmacology.
[30] R. Brambilla,et al. Blockade of A2A adenosine receptors prevents basic fibroblast growth factor‐induced reactive astrogliosis in rat striatal primary astrocytes , 2003, Glia.
[31] N. Delanty,et al. Neuroprotective properties of statins in cerebral ischemia and stroke. , 1999, Stroke.
[32] A. Thiel,et al. Penumbral probability thresholds of cortical flumazenil binding and blood flow predicting tissue outcome in patients with cerebral ischaemia. , 2001, Brain : a journal of neurology.
[33] J. Schulz,et al. Neuroprotection by the Inhibition of Apoptosis , 2000, Brain pathology.
[34] Alexei Verkhratsky,et al. Physiology and pathophysiology of the calcium store in the endoplasmic reticulum of neurons. , 2005, Physiological reviews.
[35] K. Lees. Cerestat and other NMDA antagonists in ischemic stroke , 1997, Neurology.
[36] C. Iadecola,et al. Delayed effect of administration of COX-2 inhibitor in mice with acute cerebral ischemia , 2003, Brain Research.
[37] P. Riekkinen,et al. Neuroprotective Effects of Dexmedetomidine in the Gerbil Hippocampus after Transient Global Ischemia , 1997, Anesthesiology.
[38] A Konnerth,et al. Release and sequestration of calcium by ryanodine‐sensitive stores in rat hippocampal neurones , 1997, The Journal of physiology.
[39] P. Lapchak,et al. Neuroprotective Effects of the Spin Trap Agent Disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-Oxide (Generic NXY-059) in a Rabbit Small Clot Embolic Stroke Model: Combination Studies With the Thrombolytic Tissue Plasminogen Activator , 2002, Stroke.
[40] T. Kirino. Ischemic Tolerance , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[41] K. Lees,et al. Clinical experience with excitatory amino acid antagonist drugs. , 1995, Stroke.
[42] K. Mori,et al. XBP1 mRNA Is Induced by ATF6 and Spliced by IRE1 in Response to ER Stress to Produce a Highly Active Transcription Factor , 2001, Cell.
[43] Peng-Fei Ge 葛鹏飞,et al. Ischemic preconditioning induces chaperone hsp70 expression and inhibits protein aggregation in the CA1 neurons of rats , 2008, Neuroscience Bulletin.
[44] M. Zawadzka,et al. Neuroprotectant FK506 inhibits glutamate‐induced apoptosis of astrocytes in vitro and in vivo , 2006, Journal of neurochemistry.
[45] B. Stoica,et al. Neuroprotection: challenges and opportunities. , 2007, Archives of neurology.
[46] M. Marcoli,et al. 5-HT control of ischemia-evoked glutamate efflux from human cerebrocortical slices , 2004, Neurochemistry International.
[47] L. Hendershot,et al. Herp Is Dually Regulated by Both the Endoplasmic Reticulum Stress-specific Branch of the Unfolded Protein Response and a Branch That Is Shared with Other Cellular Stress Pathways* , 2004, Journal of Biological Chemistry.
[48] Yong Yan,et al. Minocycline attenuates cognitive impairment and restrains oxidative stress in the hippocampus of rats with chronic cerebral hypoperfusion , 2008, Neuroscience bulletin.
[49] R. Villa,et al. Pharmacology of lazaroids and brain energy metabolism: a review. , 1997, Pharmacological reviews.
[50] [Therapeutically induced arteriogenesis in the brain. A new approach for the prevention of cerebral ischemia with vascular stenosis]. , 2006, Der Nervenarzt.
[51] W. Paschen. Disturbances of calcium homeostasis within the endoplasmic reticulum may contribute to the development of ischemic-cell damage. , 1996, Medical hypotheses.
[52] R. Swanson,et al. Astrocyte influences on ischemic neuronal death. , 2004, Current molecular medicine.
[53] P. Lipton,et al. Ischemic cell death in brain neurons. , 1999, Physiological reviews.
[54] W. Bursch,et al. Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy. , 1996, Carcinogenesis.
[55] T. Stone. Purines and neuroprotection. , 2002, Advances in experimental medicine and biology.
[56] W. Paschen,et al. Cellular abnormalities linked to endoplasmic reticulum dysfunction in cerebrovascular disease--therapeutic potential. , 2005, Pharmacology & therapeutics.
[57] Wenyin Chen,et al. Neuroprotection of naloxone against ischemic injury in rats: role of mu receptor antagonism , 2003, Neuroscience Letters.
[58] T. Hamilton,et al. Effects of Isradipine, an L-Type Calcium Channel Blocker on Permanent and Transient Focal Cerebral Ischemia in Spontaneously Hypertensive Rats , 1997, Experimental Neurology.
[59] J. Koistinaho,et al. Minocycline Provides Neuroprotection Against N-Methyl-d-aspartate Neurotoxicity by Inhibiting Microglia1 , 2001, The Journal of Immunology.
[60] M. Tohyama,et al. Transmission of cell stress from endoplasmic reticulum to mitochondria , 2002, The Journal of cell biology.
[61] Z. Zuo,et al. Isoflurane preconditioning reduces mouse microglial activation and injury induced by lipopolysaccharide and interferon-γ , 2008, Neuroscience.
[62] J. Axelrod,et al. Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[63] M. Schapira,et al. Regulated translation initiation controls stress-induced gene expression in mammalian cells. , 2000, Molecular cell.
[64] R. Gill. The pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate antagonists and their role in cerebral ischaemia. , 1994, Cerebrovascular and brain metabolism reviews.
[65] S. L. Mehta,et al. Molecular targets in cerebral ischemia for developing novel therapeutics , 2007, Brain Research Reviews.
[66] Randal J. Kaufman,et al. Complementary Signaling Pathways Regulate the Unfolded Protein Response and Are Required for C. elegans Development , 2001, Cell.
[67] M. Ginsberg,et al. Adventures in the Pathophysiology of Brain Ischemia: Penumbra, Gene Expression, Neuroprotection: The 2002 Thomas Willis Lecture , 2003, Stroke.
[68] Hans-Jörg Busch,et al. Arteriogenesis in Hypoperfused Rat Brain , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[69] I. Merchenthaler,et al. Neuroprotection by ovarian hormones in animal models of neurological disease , 2006, Endocrine.
[70] R. Kaufman,et al. Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. , 1999, Genes & development.
[71] D. Holtzman,et al. BDNF Protects the Neonatal Brain from Hypoxic-Ischemic InjuryIn Vivo via the ERK Pathway , 2000, The Journal of Neuroscience.
[72] G. Shore,et al. BH-3-only BIK Functions at the Endoplasmic Reticulum to Stimulate Cytochrome c Release from Mitochondria* , 2002, The Journal of Biological Chemistry.
[73] T. Obrenovitch. Molecular physiology of preconditioning-induced brain tolerance to ischemia. , 2008, Physiological reviews.
[74] S. Schachter,et al. Remacemide: current status and clinical applications , 2000, Expert opinion on investigational drugs.
[75] G. Mies,et al. Therapeutic Induction of Arteriogenesis in Hypoperfused Rat Brain Via Granulocyte-Macrophage Colony-Stimulating Factor , 2003, Circulation.
[76] C. Tanaka,et al. Neuroprotective effects of an immunosuppressant agent on diffusion/perfusion mismatch in transient focal ischemia , 2004, Magnetic resonance in medicine.
[77] Guang-yi Zhang,et al. Neuroprotection of γ‐aminobutyric acid receptor agonists via enhancing neuronal nitric oxide synthase (Ser847) phosphorylation through increased neuronal nitric oxide synthase and PSD95 interaction and inhibited protein phosphatase activity in cerebral ischemia , 2008, Journal of Neuroscience Research.
[78] G. Steinberg,et al. Hu23F2G, an Antibody Recognizing the Leukocyte CD11/CD18 Integrin, Reduces Injury in a Rabbit Model of Transient Focal Cerebral Ischemia , 1998, Experimental Neurology.
[79] R. Bartus,et al. Postischemic Administration of AK275, a Calpain Inhibitor, Provides Substantial Protection against Focal Ischemic Brain Damage , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[80] D. Ron,et al. Feedback Inhibition of the Unfolded Protein Response by GADD34-Mediated Dephosphorylation of eIF2α , 2001, The Journal of cell biology.
[81] M. Berridge. Cell signalling. A tale of two messengers. , 1993, Nature.
[82] Min Zhang,et al. Ischemic Postconditioning Inhibits Apoptosis After Focal Cerebral Ischemia/Reperfusion Injury in the Rat , 2008, Stroke.
[83] F. Pedata,et al. The protective effect of adenosine A2A receptor antagonism in cerebral ischemia , 2005, Neurological research.
[84] Ulrich Dirnagl,et al. Ischemic tolerance and endogenous neuroprotection , 2003, Trends in Neurosciences.
[85] B. Luo,et al. Ischemic Postconditioning Protects Against Global Cerebral Ischemia/Reperfusion-Induced Injury in Rats , 2008, Stroke.
[86] Z. Qin,et al. Mechanisms of lysosomal proteases participating in cerebral ischemia-induced neuronal death , 2008, Neuroscience bulletin.
[87] Hong Zhang,et al. Pinacidil reduces neuronal apoptosis following cerebral ischemia-reperfusion in rats through both mitochondrial and death-receptor signal pathways , 2007, Neuroscience bulletin.
[88] G. Kroemer,et al. Endoplasmic reticulum stress-induced cell death requires mitochondrial membrane permeabilization , 2002, Cell Death and Differentiation.
[89] R. Paules,et al. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. , 2003, Molecular cell.
[90] Amy S. Lee,et al. Induction of Grp78/BiP by Translational Block , 2003, Journal of Biological Chemistry.
[91] M. Ross,et al. Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[92] O. Hurtado,et al. Activation of Liver X Receptors Promotes Neuroprotection and Reduces Brain Inflammation in Experimental Stroke , 2008, Circulation.
[93] RobertSchmid-Elsaesser,et al. Combination Drug Therapy and Mild Hypothermia , 1999 .